Piper Sandler analyst Matt O'Brien maintains Glaukos (NYSE:GKOS) with a Overweight and raises the price target from $110 to $140.
Piper Sandler Maintains Overweight on Glaukos, Raises Price Target to $140
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.